Aileron Therapeutics Inc (NASDAQ:ALRN)
| 1.22 Delayed Data As of 3:59pm ET |  -0.04 / -3.17%Today’s Change | 0.25 Today|||52-Week Range 1.99 | +112.91% Year-to-Date |
Latest ALRN News | Press Releases
No recent news for Aileron Therapeutics Inc.
Today’s Trading
| Previous close | 1.26 |
| Today’s open | 1.24 |
| Day’s range | 1.22 - 1.25 |
| Volume | 5,104 |
| Average volume (3 months) | 1,025,073 |
| Market cap | $50.3M |
Data as of 3:59pm ET, 09/29/2020
Growth & Valuation
| Earnings growth (last year) | +44.08% |
| Earnings growth (this year) | +48.33% |
| Earnings growth (next 5 years) | +2.06% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CPIXCumberland Pharmaceu... | +0.05 | +1.58% |
| PDSBPDS Biotechnology Co... | -0.01 | -0.43% |
| MBRXMoleculin Biotech In... | +0.00 | +0.04% |
| REPHRecro Pharma Inc | -0.06 | -2.78% |
Data as of 3:59pm ET, 09/29/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$29.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
